Spark Therapeutics (NASDAQ:ONCE)
Historical Stock Chart
1 Month : From Oct 2019 to Nov 2019
By Carlo Martuscelli
The U.K.'s Competition and Markets Authority has opened an investigation into the acquisition of Spark Therapeutics Inc. by Roche Holding AG (RO.EB).
The regulator said it is looking into whether the deal will result in a substantial lessening of competition, and has set Dec. 16 as its deadline to decide whether it will continue the investigation.
Roche said it agreed to buy the Philadelphia biotechnology company in February in a bid to expand its presence in hemophilia treatment.
Write to Carlo Martuscelli at email@example.com; @carlomartu
(END) Dow Jones Newswires
October 22, 2019 02:31 ET (06:31 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.